Throughout the pandemic our role has evolved
- We changed funding criteria to support the health sector and extended thousands of Special Authorities
- We supported suppliers to ensure all medicines were available for people that needed them
- We funded treatments for COVID-19 and continue to watch for new treatment
- We were part of the team that helped broker deals for COVID-19 vaccines
-
COVID-19 treatments
We've agreed to fund 6 treatments to date.
-
COVID-19 vaccines
Read about the Vaccine Strategy and PHARMAC's role
-
Changes to funding criteria for long-acting muscarinic agonists
Spirometry not needed for COPD diagnosis..
-
Current supply issues for medicines and devices
Check the medicine notices page for stock issues and discontinuations caused by COVID-19.
-
Dispensing frequency
Which medicines have dispensing limits
-
Ivermectin
-
Hydroxychloroquine
We've limited access to proven indications.
-
OIAs about our Covid-19 response
What we were asked and how we answered.
-
Hospital medical devices and Pharmac
An update from the team